Reuters
News Agency

Sandoz results narrowly beat sales expectations
Swiss generic maker Sandoz reported a 9% jump in second quarter net sales on Wednesday, slightly above analyst expectations, as it reaped the benefits of patent expirations in its biosimilars unit.
Related Symbols
1
S
SDZNY
SDZNY
Source:
Reuters
Visit Source
Comments